eBot Bio is an early-stage AI deeptech and biotech startup focused on reducing R&D costs by ~95%. We are developing a Miniature AI Robot Scientist (MARS) that integrates large language models (LLMs) to emulate scientists' reasoning and microfluidics to replicate precise scientists' hands, achieving intelligence, miniaturization, affordability, and scalability. Our mission is to make low-cost, automated R&D accessible at an unprecedented scale.
Scientific discovery and biotech innovation deliver significant returns on investment (ROI) and societal benefits. However, R&D is bottlenecked by the substantial upfront costs of skilled scientists, instruments, and large volumes of reagents. eBot Bio (Experimental robot for bioassays) tackles this barrier by miniaturizing and automating the full bioassay workflow on MARS, a single benchtop robot—from design and sample handling to data interpretation—dramatically reducing the need for manual labor and costly hardware. Through the fusion of AI and microfluidic automation, we aim to democratize life science R&D and accelerate innovation worldwide.
Company Details
- Employees
- 3
- Founded
- -
- Address
- California Nanosystems Institute At Ucla,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://ebot.bio
- Keywords
- AI LLM, Lab Automation, Bioassays, Microfluidics.
- HQ
- Los Angeles, California
Ebot Bio Questions
Ebot Bio's website is https://ebot.bio
Ebot Bio's LinkedIn profile is https://www.linkedin.com/company/ebot-bio
Ebot Bio has
3 employees.
View email and phone details for 3
employees at Ebot Bio.
Ebot Bio's industry is
Biotechnology Research
Ebot Bio's categories are Biotechnology Research
Ebot Bio's founding year is 2025
